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Acute itch can be generated by either chemical or
mechanical stimuli, which activate separate path-
ways in the periphery and spinal cord. While sub-
stantial progress has been made in mapping the
transmission pathway for chemical itch, the central
pathway for mechanical itch remains obscure. Using
complementary genetic and pharmacological ma-
nipulations, we show that excitatory neuronsmarked
by the expression of the neuropeptide Y1 receptor
(Y1Cre neurons) form an essential pathway in the dor-
sal spinal cord for the transmission ofmechanical but
not chemical itch. Ablating or silencing the Y1Cre neu-
rons abrogates mechanical itch, while chemogenetic
activation induces scratching. Moreover, using Y1
conditional knockout mice, we demonstrate that
endogenous neuropeptide Y (NPY) acts via dorsal-
horn Y1-expressing neurons to suppress light punc-
tate touch and mechanical itch stimuli. NPY-Y1
signaling thus regulates the transmission of innoc-
uous tactile information by establishing biologically
relevant thresholds for touch discrimination and me-
chanical itch reflexes.INTRODUCTION
Itch is a protective cutaneous somatosensory modality that
drives reflexive scratching to remove harmful parasites and irri-
tants from the skin. Itch is elicited either by chemical pruritogens,
including histamine and serotonin, or by light mechanical stimuli,
such as an insect crawling across the skin (Dong and Dong,
2018; Hachisuka et al., 2018; Han and Dong, 2014; Ikoma,
2013; Ikoma et al., 2006). Although chemical and mechanical
itch function in a complementary manner to protect against cuta-
neous tissue damage, there is growing evidence that they areThis is an open access article under the CC BY-Nmediated by separate neural pathways in the periphery and spi-
nal cord.
The transmission pathway for chemical itch has been charac-
terized in some detail (Bautista et al., 2014; Dong and Dong,
2018; Hachisuka et al., 2018; Ikoma, 2013). Chemical prurito-
gens activate pruriceptive Ad and C fibers that display little or
no mechanical sensitivity (Ringkamp et al., 2011; Schmelz
et al., 1997, 2003), and these convey the itch signal from the
skin to the superficial dorsal horn.Within the dorsal horn, chem-
ical itch is transmitted by neurons expressing the gastrin
releasing peptide receptor (GRPR) (Bautista et al., 2014; Hachi-
suka et al., 2018; Han and Dong, 2014; Mishra and Hoon, 2013;
Sun et al., 2009; Sun and Chen, 2007). Thereafter, the signal is
relayed to the thalamus (Davidson et al., 2007, 2012; Johanek
et al., 2008; Ma et al., 2012; Papoiu et al., 2012; Simone
et al., 2004) and parabrachial nucleus (Campos et al., 2018;
Mu et al., 2017) by projection neurons, including those marked
by neurokinin-1 receptor (NK1R) expression (Akiyama et al.,
2015). Much less is known about mechanical itch, which is initi-
ated by the activation of low-threshold mechanoreceptors
(LTMRs) in the skin (Fukuoka et al., 2013; Han and Dong,
2014; Koch et al., 2018). Recently, we showed that mechanical
itch is selectively gated by inhibitory interneurons in the dorsal
horn that are marked by the expression of Neuropeptide Y::Cre
(NPY::Cre interneurons [INs]). Ablation of NPY::Cre INs in mice
leads to chronic scratching in the absence of an external stim-
ulus, as well as an increased tendency to scratch in response to
low-threshold mechanical stimulation of the nape, consistent
with disinhibited transmission of tactile information from the
hairy skin (Bourane et al., 2015a). This mechanical itch pheno-
type is independent of the GRPR+ neuron-dependent chemical
itch pathway, providing strong evidence for a separate me-
chanical itch pathway in the spinal cord. However, the excit-
atory spinal neurons that transmit the mechanical itch signal
and the mechanism by which the inhibitory NPY::Cre INs gate
the flow of information through this pathway remain wholly
unknown.
In this study, we delineate a central circuit for the processing
of mechanical itch that incorporates a peptidergic signalingCell Reports 28, 625–639, July 16, 2019 ª 2019 The Author(s). 625
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Y1Cre Marks a Population of Excitatory Neurons Concentrated in Laminae II-III
(A) Transverse section through the lumbar spinal cord of a P21 mouse showing Y1 mRNA expression in the dorsal horn.
(B) Section from a P42 Y1Cre; Ai14lsl-tdTom mouse showing laminar distribution of Y1-tdTomato neurons.
(C) Co-expression of tdTomato and Y1 mRNA in the dorsal horn of a P21 Y1Cre; Ai14lsl-tdTom mouse.
(D) Summary of Y1 mRNA expression (n = 3 mice).
(E and F) Transverse sections through the lumbar spinal cord of a P10 Y1Cre; Ai14lsl-tdTom mouse stained with antibodies against Lmx1b (E) and Pax2 (F).
(G) Quantification of co-expression of Y1-tdTomato with antibody-labeled Lmx1b and Pax2 in P10 Y1Cre; Ai14lsl-tdTommice (n = 5 mice). Roman numerals denote
Rexed’s laminae.
Scale bars: 50 mm (A, B, E, and F) and 10 mm (C). Data: mean ± SEM. See also Figures S1–S3.mechanism to establish normal touch discrimination. We show
that neurons in the dorsal spinal cord expressing Y1 and the tran-
scription factor Lbx1, hereafter referred to as Y1Cre neurons, are
essential for the central transmission of light punctate touch and
mechanical but not chemical itch. Ablating the spinal Y1Cre neu-
rons abolishes the chronic spontaneous scratching that occurs
following removal of the NPY::Cre INs, while ablation or silencing
spinal Y1Cre neurons renders mice insensitive to mechanical but
not chemical stimulation. We go on to demonstrate that endog-
enous NPY acts on Y1+ dorsal horn neurons to suppress light
punctate touch and mechanical itch. Lbx1Cre; Y1f/f conditional
knockout mice exhibit spontaneous scratching and hypersensi-
tivity to mechanical itch stimuli, as well as reduced thresholds for
hindpaw withdrawal from light punctate stimuli, but, like Y1Cre
neuron-ablated mice, they have normal responses to chemical
itch and pain stimuli. Conversely, selective activation of Y1 re-
ceptors or activation of NPY::Cre INs to stimulate endogenous
NPY release reduces mechanical itch responses. These data
show that the mechanical itch pathway is gated by NPY-Y1
signaling within the dorsal horn. These data also indicate that
the previously reported analgesic effects of NPY and Y1
signaling (Diaz-delCastillo et al., 2018; Duggan et al., 1991;
Hua et al., 1991; Intondi et al., 2008; Naveilhan et al., 2001; Sol-
way et al., 2011; Taiwo and Taylor, 2002) aremediated by periph-
eral sensory neurons.626 Cell Reports 28, 625–639, July 16, 2019RESULTS
Y1 ExpressionMarks a Population of Excitatory Neurons
within the LTMR-RZ
Mechanical itch is mediated by light touch information trans-
mitted to the spinal cord by LTMRs innervating the hairy skin
(Fukuoka et al., 2013); this information is then subject to inhibi-
tory gating by locally projecting NPY::Cre INs in the dorsal horn
(Bourane et al., 2015a). We therefore centered our search for the
excitatory neurons that transmit the mechanical itch signal on
glutamatergic cells that are located within the LTMR recipient
zone (LTMR-RZ) of the dorsal horn (Abraira et al., 2017). This
zone (laminae IIi–IV) contains molecularly diverse excitatory
populations that are extensively innervated by LTMRs (Abraira
et al., 2017; Abraira and Ginty, 2013; Koch et al., 2018). Of
particular interest was a subset of dorsal horn excitatory neu-
rons distinguished by expression of the inhibitory Y1 receptor
(NPYR1; Ha¨ring et al., 2018; Melnick, 2012; Miyakawa et al.,
2005; Sathyamurthy et al., 2018). Y1 mRNA-positive neurons
are distributed throughout the LMTR-RZ and are also present
in laminae I–IIo (Figure 1A). In the spinal cords of adult Y1Cre
(NPYR1Cre) knockin mice (Padilla et al., 2016) carrying the
Ai14lsl-tdTom reporter (Madisen et al., 2010), Y1Cre-derived cells
were enriched in laminae IIi/III, with additional cells present in
laminae I, IIo, and IV (Figures 1B and S1C). 88.8% ± 2.0% of
Y1+ cells in the dorsal horn co-expressed the Y1Cre-dependent
tdTomato reporter, with 62.5% ± 7.9% of tdTomato+ neurons
showing Y1 expression (Figures 1C and 1D). Likewise, when
Y1Cre; Ai14lsl-tdTom mice were crossed with a Y1::EGFP trans-
genic reporter line (Gene Expression Nervous System Atlas
[GENSAT]), 84.4% ± 4.6% of the EGFP+ neurons co-expressed
tdTomato (Figures S1A–S1C) and 53.8% ± 3.4% of the tdTo-
mato+ neurons co-expressed EGFP. These data suggest that
Y1Cre captures dorsal horn neurons that exhibit transient or
low-level Y1 gene expression in addition to cells that show
persistent expression, as has been noted for other Cre drivers
(e.g., Bourane et al., 2015a; Duan et al., 2014; Peirs et al., 2015).
The vast majority of Y1Cre-derived neurons are excitatory, with
82.4%± 6.9%expressing Lmx1b andonly 0.4%± 0.2%express-
ing the inhibitory neuron marker Pax2 (Figures 1E–1G). Further-
more, some tdTomato+ cells co-expressed markers of excitatory
neuron populations that have been implicated in the transmission
of mechanical stimuli, including cMaf+ neurons (Wende et al.,
2012), retinoid-related orphan receptor alpha (RORa)+ neurons
(Bourane et al., 2015b), and Somatostatin (Sst)+ neurons (Chris-
tensen et al., 2016; Duan et al., 2014; Huang et al., 2018). Co-
expression was also seen in gastrin releasing peptide (GRP)-ex-
pressing neurons (Mishra and Hoon, 2013; Solorzano et al.,
2015), as well as in NK1R+ neurons in lamina I and laminae III–
IV (Akiyama et al., 2013, 2015; Carstens et al., 2010). By contrast,
there was no overlap with neurons that express GRPR, or cells
expressing the astrocytic markers S100b or glial fibrillary acidic
protein (GFAP) (Figure S2).
In keeping with this analysis, sparse labeling of Y1Cre neu-
rons in laminae I–IV with EnvA-pseudotyped DG-dsRed-
Express rabies virus revealed cell morphologies that are
characteristic of excitatory neurons. These include central-,
vertical-, and radial-like cell types in lamina II (Grudt and
Perl, 2002), and projection neurons in lamina I that likely corre-
spond to NK1R+ projection neurons (Akiyama et al., 2015; Bru-
movsky et al., 2006; Szabo et al., 2015). We also observed
fusiform neurons in lamina II and multipolar neurons in laminae
III–IV, some of which were previously shown to express Y1
(Figure S3; Brumovsky et al., 2006).
To determine whether Y1Cre neurons receive direct LTMR in-
puts, we performed injections of cholera toxin B (CTb) into
either the hairy skin of the thigh or the glabrous skin of the
plantar hindpaw of adult Y1Cre; Ai14lsl-tdTom mice. CTb-labeled
boutons from fibers innervating either region were found in
close apposition to Y1Cre-tdTomato somata, andmany of these
displayed immunoreactivity for vesicular glutamate transporter
1 (vGluT1), which labels myelinated Aß and Ad LTMRs in the
LTMR-RZ (Figures 2A and 2B; n = 3 mice assessed per condi-
tion) (Todd et al., 2003).
The LTMR subtypes that innervate Y1Cre neurons were further
analyzed by intersectional monosynaptic retrograde tracing with
EnvA-pseudotyped DG-mCherry rabies virus (Figures 2C–2J)
(Albisetti et al., 2017; Bourane et al., 2015a, 2015b; Wickersham
et al., 2007). Retrograde mCherry expression was observed in
multiple cutaneous LTMR subtypes, including c-Ret+/IB4 Aß-
LTMRs, TrkC+/parvalbumin Aß-LTMRs, TrkB+ Ad-LTMRs, and
putative LTMRs that express calcitonin gene-related peptide
(CGRP) and neurofilament 200 (NF200) (Bourane et al., 2015b;Lawson et al., 2002). Dorsal root ganglion (DRG) neurons
expressing calbindin, which innervate Meissner corpuscles,
were also labeled (Figure 2I). Proprioceptors marked by the
expression of parvalbumin were largely spared, and Aß fibers ex-
pressing calretinin, which innervate Pacinian corpuscles, were
never detected (Figure 2J). In summary, this analysis provides
clear evidence that the Y1Cre neurons are extensively innervated
by cutaneous LTMR fibers.
Y1Cre Neurons Are Essential Components of the
Mechanical Itch Pathway Gated by Inhibitory NPY::
Cre INs
NPY::Cre IN ablation causes a mechanical itch phenotype that is
markedby increasedspontaneoushindlimbscratching (Figure3A;
Bourane et al., 2015a).We therefore set about examining whether
the Y1Cre neurons in the dorsal horn transmit the mechanical itch
signal using a genetic epistasis strategy entailing diphtheria toxin
(DT)-mediated ablation of both theNPY::Cre/Lbx1 andY1Cre/Lbx1
populations. Ablation of dorsal horn NPY::Cre INs alone signifi-
cantly increased spontaneous scratching 1 week after DT treat-
ment, from12± 2 scratch episodesper 30-min observation period
in FlpO controls to 100 ± 17 episodes in ablated animals (Figures
3A, S4A, S4D, and S4E). Strikingly, this increase in spontaneous
scratching was completely abolished following ablation of both
the Y1Cre and NPY::Cre populations in DT-treated Y1Cre; NPY::
Cre; Lbx1FlpO; Tauds-DTR; Ai65ds-tdTom mice (Figures 3A, S4B,
S4D, and S4E). These findings demonstrate that the Y1Cre neu-
rons are required for the expression of themechanical itch pheno-
type in mice lacking NPY::Cre-derived inhibitory INs.
Sst expression partially overlaps with Y1 expression in lamina
II (Figures S2E–S2G; Zhang et al., 1999), and Sst signaling has
been implicated in chemical itch transmission (Christensen
et al., 2016; Huang et al., 2018; Kardon et al., 2014).We therefore
set out to test whether NPY::Cre IN-gated scratching is medi-
ated by Sst+ neurons in the dorsal horn. Strikingly, in contrast
to the negation of scratching that occurs upon Y1Cre neuron
depletion in NPY::Cre IN-ablated mice, simultaneous ablation
of the NPY::Cre and Sst+ populations did not reduce scratching
as compared to NPY::Cre IN-ablated controls (Figures 3A and
S4C–S4E; p > 0.05). Furthermore, removing the Sst+ neurons
alone did not alter spontaneous scratching or responses to
mechanical stimulation of the nape (Figure S5). These data
reveal that dorsal horn neurons expressing Y1, either transiently
or persistently, are necessary for transmitting the light touch
modalities that drive mechanical itch, whereas those that ex-
press Sst, including Sst+/Y1+ neurons, are not.
Y1Cre Neurons Selectively Transmit the
Mechanosensory Stimuli That Drive Mechanical Itch
We next examined the function of the Y1Cre neurons in transmit-
ting the itch sensation that is generated by low-threshold me-
chanical irritation of the hairy skin. Mechanical itch induction
was assessed using a modified alloknesis assay (Akiyama
et al., 2012) inwhich a low-force (0.16g) vonFrey hairwas applied
to the hairy skin of the nape, and scratching responses were re-
corded over ten trials.Whereas nape stimulation elicited scratch-
ing in 22.7% ± 4.7% of trials in control mice, it did so in only
3.6% ± 2.3% of trials in which the Y1Cre neurons were ablatedCell Reports 28, 625–639, July 16, 2019 627
Figure 2. Y1Cre Neurons Receive Extensive
LTMR Input
(A andB)ExamplesofY1Cre neurons in lamina IIi from
lumbarspinalcordsectionsofP42Y1Cre;Ai14lsl-tdTom
mice injectedwithCTb into: the hairy skinof the thigh
(A) and the glabrous skin of the hindpaw (B).
Immunolabeled CTb+ contacts (blue) displayed
vGluT1 immunoreactivity (green, arrowheads).
(C) Section through the lumbar dorsal horn of a P10
Y1Cre; Lbx1FlpO; R26ds-HTBmouse injectedwithEnvA
G-deleted rabies-mCherry virus. Arrowheads indi-
cate infected Y1Cre neurons. mCherry+/GFP cells
represent transsynaptically labeled presynaptic
neurons.
(D) Summary of antibody-labeled myelinated sen-
sory afferent subtypes that are presynaptic to the
Y1Cre neurons, expressed as a percentage of
mCherry+ neurons (n = 4 mice).
(E–J) Sections from P10 Y1Cre; Lbx1FlpO; R26ds-HTB
lumbar DRGs showing presynaptically labeled sen-
soryneurons(red) thatexpressc-Ret (E),TrkCbutnot
parvalbumin (PV;F),TrkB (G), calcitoningene-related
peptide (CGRP) and neurofilament 200 (NF; H), and
calbindin (CB; I), but not PV or calretinin (CR; J).
Arrowheads indicate co-labeled sensory afferents.
CB, calbindin;CR, calretinin;NF, neurofilament; PV,
parvalbumin. Scale bars: 5 mm (B) and 100 mm (C
and E–J). Data: mean ± SEM. See also Figure S4.(Figures 3B and S6A–S6B). A similar reduction in scratching was
observed when the Y1Cre neurons were silenced in Y1Cre;
Lbx1FlpO; R26ds-hM4D mice treated with clozapine N-oxide
(CNO), as compared with CNO-treated Y1Cre;R26ds-hM4D control
mice that lack FlpO-dependent expression of the hM4D receptor
(Figure 3C). Conversely, scratching was greatly enhanced when
the Y1Cre neurons were activated in Y1Cre; Lbx1FlpO; R26ds-hM3D
animals (Figure 3D), which is consistent with heightened sensi-
tivity to low-threshold tactile stimulation. There was also a628 Cell Reports 28, 625–639, July 16, 2019marked increase in the number of sponta-
neous hindlimb scratching bouts over a
30-min period following hM3D-mediated
activation of theY1Cre neurons (Figure 3E).
We then considered the possibility
that the increases in spontaneous and
evoked scratching seen inY1Cre; Lbx1FlpO;
R26ds-hM3D mice might be attributable to
the activation of the chemical itch pathway
that is dependent on GRPR+ neurons. As
previously shown, chloroquine-induced
chemical itch was strongly reduced in
wild-type mice following ablation of the
GRPR+ neurons by intrathecal (i.t.) injec-
tion of saporin-conjugated bombesin
(BOM-SAP; Figures S6C–S6E) (Bourane
et al., 2015a; Huang et al., 2018; Sun
et al., 2009). By contrast, scratching re-
sponses to nape stimulation were unaf-
fected (Figure 3F). Consistent with these
results, neither the evoked nor sponta-
neous scratching seen following activationof Y1Cre neurons was affected by ablation of the GRPR+ neurons
(Figures 3G and 3H). These data agree with our previous report
that spontaneous scratching induced by removal of NPY::Cre
INs is not affected by ablation of the GRPR+ neurons (Bourane
et al., 2015a), despite our finding that the Y1Cre neurons include
some GRP-expressing neurons (Figures S2C, S2F, and S2G).
We next considered whether the pathways for chemical and
mechanical itch transmission converge downstream of the
GRPR+ neurons on lamina I NK1R+ neurons, given that Y1Cre
A B C D E
F G H
I J K L M
Figure 3. Y1Cre Neurons within the Dorsal Horn Transmit Mechanical but Not Chemical Itch
(A) Ablation of dorsal horn NPY::Cre INs increases spontaneous scratching in NPY::Cre; Lbx1FlpO; Tauds-DTR; Ai65ds-tdTom mice (n = 16) compared with
DT-treated NPY::Cre; Tauds-DTR; Ai65ds-tdTom controls that lack DT-receptor expression (n = 11). Ablation of the Y1Cre and NPY::Cre IN populations in Y1Cre;
NPY::Cre; Lbx1FlpO; Tauds-DTR; Ai65ds-tdTom mice abolishes scratching (n = 11). Scratching is unaffected when Sst+ neurons are ablated together with the
NPY::Cre INs in SstCre; NPY::Cre; Lbx1FlpO; Tauds-DTR; Ai65ds-tdTommice (n = 13). One-way ANOVA and Bonferroni post hoc tests were used to assess statistical
differences.
(B and C) Reduced scratching in response to stimulation of the nape with a 0.16-g von Frey hair in Y1Cre; Lbx1FlpO; Tauds-DTR; Ai65ds-tdTom mice treated with DT
(n = 14) compared with saline-treated controls (n = 11; B), and in Y1Cre; Lbx1FlpO; R26ds-hM4D mice treated with clozapine N-oxide (CNO; n = 8) compared with
Y1Cre; R26ds-hM4D controls, which lack FlpO-dependent hM4D expression (n = 8; C).
(D) Enhanced scratching in response to stimulation of the nape in CNO-treated Y1Cre; Lbx1FlpO; R26ds-hM3D mice (n = 6) compared with Y1Cre; R26ds-hM3D
controls (n = 6).
(E) Spontaneous scratching in CNO-treated Y1Cre; Lbx1FlpO; R26ds-hM3D mice (n = 8) is enhanced over a 30-min period compared with control mice (n = 6).
(F) Scratching responses are unchanged in wild-type mice treated with bombesin-saporin (BOM-SAP; n = 6) to ablate GRPR+ neurons compared with controls
injected with saporin (SAP; n = 8).
(G and H) Ablation of GRPR+ neurons in Y1Cre; Lbx1FlpO; R26ds-hM3D mice does not alter evoked scratching (G; BOM-SAP, n = 8; SAP, n = 7) or spontaneous
scratching (H; BOM-SAP, n = 7; SAP, n = 7) following CNO injection.
(I) Scratching responses are unchanged in wild-type mice treated with [Sar9, Met(O2)
11]-substance P-SAP (SSP-SAP; n = 10) to ablate NK1R+ neurons compared
to SAP-injected controls (n = 11).
(legend continued on next page)
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and NK1R expression partially overlap (Figures S2D, S2F, and
S2G) and evidence that NK1R+ projection neurons convey
chemical itch sensation to key supraspinal regions for the inte-
gration of aversive stimuli (Carstens et al., 2010; Akiyama
et al., 2013, 2015). Ablation of the NK1R+ neurons by injection
of saporin conjugated to the NK1R ligand [Sar9, Met(O2)
11]-
substance P (SSP-SAP) significantly attenuated chloroquine-
induced itch (Figures S6F–S6H) consistent with previous reports
(Carstens et al., 2010). However, NK1R+ neuron ablation failed to
modulate mechanically evoked itch in wild-type mice (Figure 3I),
nor did it alter the rate of evoked or spontaneous scratching that
occurs when the Y1Cre neurons are activated (Figures 3J and
3K). Ablation of the NK1R+ neurons also did not alleviate scratch-
ing induced by ablation of NPY::Cre INs (Figure 3L).
As a final test to exclude the possibility that Y1Cre neurons are
interposed in the chemical itch circuitry, we assessed scratching
in Y1Cre neuron-ablated mice following injection of chloroquine,
histamine, compound 48/80 or SLIGRL into the skin behind the
ear. Scratching responses to all four pruritogens remained intact
in Y1Cre neuron-ablated mice (Figure 3M), confirming that these
cells are not required for chemical itch, Together, these data indi-
cate that that the minority of Y1Cre neurons that co-express
NK1R are dispensable for mechanical itch sensation.
Our demonstration that the Y1Cre neurons are essential for me-
chanical itch led us to ask whether the Y1Cre neurons have a role
in transmitting low-threshold mechanical stimuli. Sensitivity to
light punctate touch, as assessed by von Frey hair stimulation
of the glabrous skin, was significantly reduced after ablating or
silencing the Y1Cre neurons (Figures 4A and 4B). Conversely,
sensitivity was elevated by activation of the Y1Cre neurons (Fig-
ure 4C). However, responses to light dynamic touch, as as-
sessed by gentle brushing, were unaffected (Figure 4D). This
finding is consistent with our observation that there is little, if
any, overlap between the Y1Cre andRORa+ neuronal populations
(Figures S2B, S2F, and S2G), the latter of which transmits dy-
namic touch (Bourane et al., 2015b). Sensitivity to acute pain,
as assessed by the pinprick and Randall-Sellito tests, was
largely unchanged in Y1Cre neuron-ablated mice, as were re-
sponses to pain chemically induced by intradermal injection of
capsaicin or formalin. Thermal pain, as assessed by the hot-
plate and Hargreaves assays, was likewise unaffected (Figures
4E–4J). Together, these findings suggest that the Y1Cre popula-
tion of neurons is largely specialized for transmitting light touch
information, and they play little or no role in relaying chemical
itch, noxious mechanical, or thermal information.
NPY Peptide Signaling Regulates Mechanical Itch
Transmission
The underlying signaling mechanisms that contribute to the
gating of mechanical itch by the NPY::Cre INs have not been(J and K) In Y1Cre; Lbx1FlpO; R26ds-hM3D mice, ablation of NK1R+ neurons does n
n = 10; SAP, n = 7) scratching following CNO injection.
(L) Unchanged scratching in NPY::Cre; Lbx1FlpO; Tauds-DTR; Ai65ds-tdTom mice 2
(SSP-SAP, n = 9; SAP, n = 8).
(M) Unchanged scratching over a 30-min period in Y1Cre neuron-ablatedmice follo
n = 6; ablated, n = 8), compound 48/80 (control, n = 6; ablated, n = 8), and SLIG
*p < 0.05, **p < 0.01, ***p < 0.001, NS, not significant. Data: mean ± SEM. See a
630 Cell Reports 28, 625–639, July 16, 2019established. In Y1::EGFP; NPY::Cre mice injected intraspinally
(T13-L1 levels) with an AAV2/1-hSyn-DIO-SypHTomato virus,
lamina II EGFP+ cell bodies displayed tdTomato+ synaptic con-
tacts from NPY::Cre INs (Figures 5A and 5B; n = 3 mice). These
contacts colocalized with vesicular GABA (gamma-aminobutyric
acid) transporter (VGAT), indicating that NPY::Cre INs provide
inhibitory synaptic inputs to Y1+ neurons (Figure 5A). Strikingly,
many puncta also had NPY immunoreactivity (Figure 5B), with
multiple NPY immunoreactive puncta being co-localized with
the postsynaptic marker gephyrin on Y1-tdTomato+ somata in
Y1Cre; Ai14lsl-tdTom mice (Figure 5C; n = 3).
To confirm that the NPY::Cre INs form functional synapses
onto Y1+ neurons, we performed whole-cell patch-clamp re-
cordings from lamina IIi Y1-EGFP cells in spinal cord sections
from Y1::EGFP; NPY::Cre; Lbx1FlpO; R26ds-ReaChR mice (Hooks
et al., 2015). Following current injection, the Y1-EGFP neurons
displayed either single (20%) or phasic firing patterns
(80%; n = 32) that are characteristic of dorsal excitatory neurons
(Abraira et al., 2017; Grudt and Perl 2002; Koch et al., 2018). We
then blocked glutamatergic transmission with kynurenic acid
and recorded from Y1-EGFP neurons at a holding potential of
30 mV. Under these conditions, we observed inhibitory cur-
rents in 11/30 neurons following red-light excitable channelrho-
dopsin (ReaChR)-mediated activation of the NPY::Cre INs
(mean amplitude: 57.3± 15.6 pA). These currents were abolished
in 7/7 neurons following application of strychnine and picrotoxin
(Figures 5D–5F), demonstrating the NPY::Cre INs form func-
tional inhibitory synapses onto excitatory Y1+ neurons within
the dorsal horn.
The intriguing finding that the Y1Cre neurons are contacted by
processes containing putative NPY+ dense core vesicles sug-
gested to us that NPYpeptidergic signaling via the Y1Cre neurons
might also contribute to the gating of the mechanical itch
pathway. To assess the role of Gi-mediated inhibitory Y1
signaling within the dorsal horn, we crossed Lbx1Cre (Sieber
et al., 2007) with Y1f/f mice (Bertocchi et al., 2011) to remove
Y1 from dorsal horn neurons, sparing ventral, peripheral, and
supraspinal neurons. Lbx1Cre; Y1f/f mice exhibited spontaneous
scratching at P42, as well as elevated sensitivity to nape stimu-
lation (Figures 6A and 6B). Similarly, both spontaneous and
evoked scratching were elevated by the Y1 antagonist BIBP
3226 (Wang et al., 2016) acting at dorsal horn Y1 receptors (Fig-
ures 6C–6D and S7A–S7B). Likewise, elevated spontaneous
scratching was observed following administration of another
Y1 antagonist, BMS 193885 (Antal-Zimanyi et al., 2008), and in
NPY knockout mice (Figure S7C) (Karl et al., 2008). Conditional
knockout of Y1 enhanced hindpaw sensitivity to light punctate
touch but did not modulate responses to dynamic touch (Figures
6E and 6F) or the frequency of scratching in response to
histaminergic and non-histaminergic chemical itch stimuliot alter evoked (J; SSP-SAP, n = 9; SAP, n = 7) or spontaneous (K; SSP-SAP,
weeks after NK1R+ neuron ablation and 1 week following DT administration
wing injection of chloroquine (control, n = 9; ablated, n = 11), histamine (control,
RL (control, n = 7; ablated, n = 8).
lso Figures S4–S6.
A B C D
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Figure 4. Y1Cre Neurons Selectively Transmit Light Touch Information
(A and B) Sensitivity to von Frey hair stimulation of the hindpaw glabrous skin is reduced following Y1Cre neuron ablation (A; control, n = 6; ablated, n = 9) or
silencing (B; control, n = 8; silenced, n = 8).
(C) Glabrous skin sensitivity to von Frey hair stimulation is elevated following Y1Cre neuron activation (control, n = 6; activated, n = 6).
(D–F) Responses to dynamic touch (D; control, n = 11; ablated, n = 13), pinprick (E; control, n = 11; ablated, n = 13), and Randall-Selitto (F; control, n = 12; ablated,
n = 9) are unchanged after Y1Cre neuron ablation.
(G and H) Chemical pain responses following hindpaw injection of capsaicin (G; control, n = 11; ablated, n = 9) or formalin (H; control, n = 9; ablated, n = 7) are not
altered following Y1Cre neuron ablation.
(I and J) Y1Cre neuron-ablatedmice show normal heat responses as assessed by the hot plate (I; control, n = 12; ablated, n = 9) and Hargreaves (J; control, n = 12;
ablated, n = 9) assays.
**p < 0.01, ***p < 0.001. Data: mean ± SEM.(Figure 6G). The duration and rate (duration/frequency) of
scratching induced by compound 48/80 were also unchanged
(Figures 6H and 6I; Gao et al., 2018). Likewise, responses to me-
chanical, chemical, and thermal pain stimuli were not affected(Figures 6J–6N). These data indicate that NPY-Y1 signaling in
the dorsal horn has a selective role in the modulation of light
punctate touch information from both the hairy and glabrous
skin and, as a consequence, functions to gate mechanical itch.Cell Reports 28, 625–639, July 16, 2019 631
Figure 5. Y1Cre Neurons Receive VGAT+ and
NPY+ Synaptic Contacts from NPY::Cre INs
(A and B) Examples of GFP-labeled cells from the
lumbar spinal cord of a P60 Y1::EGFP; NPY::Cre
transgenic mouse. Presynaptic contacts (red)
from NPY::Cre INs onto Y1/EGFP+ cells were visu-
alized with a Cre-dependent AAV2/1-hSyn-DIO-
SypHTom virus. Putative synaptic boutons marked
by VGAT (blue; A) and NPY (blue; B) immunoreac-
tivity are indicated by arrowheads.
(C) Examples of synaptic puncta labeled with anti-
bodies against NPY (green) and gephyrin (blue) on a
Y1-tdTomato+ cell body in the lumbar spinal cord of
a P42 Y1Cre; Ai14lsl-tdTom mouse (arrowheads).
(D) Schematic illustrating experimental conditions
used to assess synaptic connectivity between
NPY::Cre INs and Y1Cre neurons.
(E) ReaChR-mediated activation of NPY::Cre IN
generated monosynaptic outward currents in lam-
ina IIi Y1-EGFP+ neurons in P14-21 Y1::EGFP;
NPY::Cre; Lbx1FlpO; R26ds-ReaChR spinal cord slices
in the presence of kynurenic acid (KA; 1.5 mM) at a
holding potential of 30 mV. These currents were
abolished following application of 1 mM strychnine
and 60 mM picrotoxin (n = 7 cells from 5 mice).
***p < 0.001. The statistical difference was deter-
mined by the two-tailed, paired t test.
(F) Traces recorded from a Y1-EGFP+ neuron
showing a monosynaptic inhibitory current elicited
by NPY::Cre activation (purple trace) and no
response following bath application of strychnine
and picrotoxin (black trace).
Scale bars: 5 mm.The role of Y1 signaling in the regulation ofmechanical itch was
further assessedby administeringNPYor the selectiveY1 agonist
[Leu31, Pro34]-NPY (Gelfo et al., 2011) to NPY::Cre; Lbx1FlpO;
Tauds-DTR; Ai65ds-tdTom mice 1 week after ablating the NPY::Cre
INs. Both agonists relieved spontaneous scratching in the NPY::
Cre IN-ablatedmice (Figures 7A and S7D). Furthermore, injection
of NPY (Figure S7E) or [Leu31, Pro34]-NPY reduced sensitivity to
nape stimulation, with this effect being abolished when [Leu31,
Pro34]-NPY was administered to Lbx1Cre; Y1f/f mice, confirming
the dorsal horn as the site of NPY action (Figures 7B and S7F).
As a final test of the functional interaction between the NPY::
Cre and Y1+ neurons, we assessed itch sensitivity following che-632 Cell Reports 28, 625–639, July 16, 2019mogenetic activation of NPY::Cre INs.
When NPY::Cre INs were selectively acti-
vated, evoked scratching was reduced
compared to controls (Figure 7C). This
reduction in scratching was negated
by co-injecting BIBP 3226 with CNO, indi-
cating that the inhibition of itch by NPY::
Cre INs is in large part dependent on
the actions of NPY on the Y1+ neurons
(Figure 7D). Importantly, the inhibition
of itch by NPY::Cre IN activation was
specific to mechanical itch, as chloro-
quine-induced scratching was unaffected
(Figure 7E).The activation of NPY::Cre INs also caused a pronounced
reduction in the sensitivity of the glabrous skin to light punctate
touch, as well as more moderate reductions in responses to
dynamic touch and acute pain (Figures 7F–7H). These effects
were not observed when BIBP 3226 was administered (Figures
7I–7K), implying that they were mediated by enhanced release
of NPY. Given that dorsal horn Y1+ neurons do not transmit dy-
namic touch and acute pain, it is likely that the modulation of
these modalities following NPY::Cre IN activation results from
ectopic activation of Y1 receptors expressed by sensory neu-
rons. Taken together, these data support a model in which light
punctate touch and mechanical itch are strongly regulated by
A B C D E
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Figure 6. NPY-Y1 Receptor Signaling within the Dorsal Horn Gates Mechanical Itch and Light Punctate Touch
(A and B) Mice lacking the Y1 receptor in dorsal horn neurons exhibit pronounced spontaneous scratching (A; Lbx1Cre; Y1f/f, n = 10; Y1f/f control, n = 12) and
hypersensitivity to light punctate mechanical stimulation of the nape (B; Lbx1Cre; Y1f/f, n = 7; Y1f/f control, n = 9).
(C) The Y1 antagonist BIBP 3226 (1 mg kg-1, intraperitoneally [i.p.]) increases spontaneous scratching in control (n = 8) but not conditional knockout mice (n = 12).
Two-tailed, paired t tests were used to assess statistical differences.
(D) BIBP 3226 causes hypersensitivity to nape stimulation (n = 12; vehicle, n = 12).
(E and F) Lbx1Cre; Y1f/fmice have reduced hindpaw von Frey thresholds (E; Lbx1Cre; Y1f/f, n = 8; Y1f/f control, n = 8) but responses to dynamic touch are unaltered
(F; Lbx1Cre; Y1f/f, n = 8; Y1f/f control, n = 9).
(G–I) Deletion of Y1 from dorsal horn neurons does not alter scratching frequency in response to chloroquine (Lbx1Cre; Y1f/f, n = 11; Y1f/f control, n = 9) or
scratching frequency (G), duration (H), or rate (duration/frequency; I) in response to compound 48/80 (Lbx1Cre; Y1f/f, n = 14; Y1f/f control, n = 10).
(J–N) Deletion of Y1 from dorsal horn neurons does not affect sensitivity to acute mechanical pain as assessed by pinprick (J; Lbx1Cre; Y1f/f, n = 9; Y1f/f control,
n = 9) or the Randall-Selitto test (K; Lbx1Cre; Y1f/f, n = 8; Y1f/f control, n = 6), chemical nociception (L; Lbx1Cre; Y1f/f, n = 8; Y1f/f control, n = 8), or thermal pain as
assessed by the hot plate (M; Lbx1Cre; Y1f/f, n = 9; Y1f/f control, n = 9) or Hargreaves tests (N; Lbx1Cre; Y1f/f, n = 8; Y1f/f control, n = 6).
*p < 0.05 and ***p < 0.001. NS, not significant. Data: mean ± SEM.
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Figure 7. NPY-Y1 Receptor Signaling Determines Sensitivity to Mechanical Itch Stimuli
(A) Spontaneous scratching in NPY::Cre; Lbx1FlpO; Tauds-DTR; Ai65ds-tdTom mice 1 week after DT treatment was reduced following injection of NPY (100 mg kg-1,
i.p.; n = 9) or the selective Y1 receptor agonist [Leu31, Pro34]-NPY (100 mg kg-1, i.p.; n = 6) when compared with vehicle.
(B) Evoked scratching is reducedwhen Y1f/fmice (n = 8) but not Lbx1Cre; Y1f/fmice (n = 9) are injectedwith [Leu31, Pro34]-NPY (100 mg kg-1, i.p., n = 8; vehicle, n = 8).
(C and D) hM3D-mediated activation of the NPY::Cre INs reduces scratching in response to mechanical stimulation of the nape compared with controls
(NPY::Cre; Lbx1FlpO; R26ds-hM3D, n = 13;NPY::Cre; R26ds-hM3D controls, n = 11; C) but not when Y1 receptors are inhibited by BIBP 3226 (n = 7; controls, n = 9; D).
(E) Unchanged chloroquine-induced scratching following activation of the NPY::Cre INs (n = 12; controls, n = 12).
(F–H) Activation of NPY::Cre INs reduces sensitivity to von Frey hair (F), brush (G), and pinprick (H) stimulation of the plantar hindpaw (n = 13; controls, n = 11).
(I–K) Activation of NPY::Cre INs does not alter sensitivity to von Frey hair (I), brush (J), and pinprick (K) stimulation following Y1 receptor blockade by BIBP 3226
(n = 9; BIBP 3226-injected controls, n = 7).
(L) Schematic showing proposed dorsal horn circuitry for mechanical and chemical itch. Dyn, dynorphin; Nppb, natriuretic peptide B; NPRA, natriuretic peptide
receptor A; PN, projection neuron; Sst2A, Sst 2A receptor. Italics indicate neurotransmitters/neuropeptides.
Two-tailed, paired (A and B) or unpaired (C–K) t tests were used to assess statistical differences. *p < 0.05, **p < 0.01, ***p < 0.001. NS, not significant. Data: mean
± SEM (B–L). See also Figure S7.
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the actions of NPY on inhibitory Y1-bearing neurons in the dor-
sal horn.
DISCUSSION
In this study we have identified the population of excitatory neu-
rons in the dorsal spinal cord that are essential for transmitting
the mechanosensory stimuli that drive mechanical itch. These
neurons are marked by Y1 receptor expression and they define,
together with NPY::Cre inhibitory INs in the dorsal horn, a central
pathway formechanical itch transmission that is distinct from the
well-described GRP-GRPR chemical itch pathway (Figure 7L).
Scratching in response to mechanical stimulation is abolished
when the Y1Cre neurons are ablated, while activation of the
Y1Cre neurons increases scratching in response to mechanical
stimulation. Our results also reveal a prominent role for NPY pep-
tidergic signaling in regulating light punctate touch sensitivity
and mechanical itch, which is mediated by Y1+ neurons in the
dorsal horn. We propose that NPY inhibitory signaling normally
facilitates the discrimination of light touch stimuli, and disrupting
it promotes a chronic itch phenotype and mechanical hyperkne-
sis/alloknesis.
Dorsal Horn Y1Cre Neurons Transmit Low-Threshold
Mechanical Stimuli
The light punctate touch and mechanical itch phenotypes we
observe upon manipulation of the Y1Cre neurons are consistent
with their innervation by mechanosensory LTMR afferents from
both the glabrous and hairy skin (Figure 2). Whereas the Y1Cre
neurons encompassmultiple cell types within the LTMR-RZ (Fig-
ures S2 and S3), our findings suggest that only a subset of these
cells are required for mechanical itch responses, and this subset
appears to be distinct from those Y1Cre neurons that express Sst
or NK1R, as ablating the Sst+ or NK1R+ neurons fails to disrupt
the mechanical itch pathway (Figures 3 and S5).
Touch information appears to be broadly distributed between
overlapping molecularly defined populations within the LTMR-
RZ that includeY1+, RORa+, Sst+, vGlut3+, and calretinin+ neurons
(this study; Abraira et al., 2017; Abraira and Ginty, 2013; Bourane
et al., 2015b; Duan et al., 2014; Peirs et al., 2015). Interestingly,
the role of the Y1+ neurons in processing touch information ap-
pears to be limited to punctuate touch, since they are dispensable
for transmitting dynamic light touch information (Figure 3), which is
instead largely transmittedbyexcitatoryRORa+ INs in laminae IIi/III
(Bourane et al., 2015b). The contribution that dynamic touch and
the RORa+ INs make to mechanical itch is still unclear.
The possibility that the Y1Cre neurons may contribute to the
transmission of other cutaneous modalities is suggested by our
observation that some Y1Cre neurons reside in laminae I–IIo, sub-
sets of which are Sst+ neurons, which have been implicated in
acutemechanicalpainand lamina INK1R+neurons,which transmit
chemical pain (Brumovsky et al., 2002; Duan et al., 2014; Mantyh
et al., 1997; Nichols et al., 1999). Somewhat surprisingly, our func-
tional analyses did not reveal a role for the Y1Cre neurons in acute
mechanical pain or responses to noxious heat or chemical stimuli
(Figure 4). Moreover, the absence of a pain phenotype following
Y1Cre neuron ablation or activation suggests the Y1Cre/SstCre and
Y1Cre/NK1R+ neurons are dispensable for pain transmission.Chemical itch transmission was also unaffected following
ablation of the Y1Cre neurons (Figure 3), with this study and our
previous functional analysis of the NPY::Cre INs (Bourane
et al., 2015a) providing strong evidence that the pathways for
mechanical and chemical itch are largely segregated in the pe-
riphery and dorsal spinal cord (Figures 3 and 7L). Although the
Y1Cre population partially overlaps with NK1R+, Sst+, and
GRP+ neurons that have been implicated in chemical itch trans-
mission (Albisetti et al., 2019; Christensen et al., 2016; Fatima
et al., 2019; Huang et al., 2018; Kardon et al., 2014; Mishra
and Hoon, 2013), those embedded within the Y1Cre population
appear to be dispensable for chemical itch.
Mechanical and chemical itch stimuli produce indistinguish-
able sensations in humans, and both trigger scratching
(Fukuoka et al., 2013). This suggests central convergence of
the mechanical and chemical itch pathways, a possibility sup-
ported by observations that chemical pruritogens can cause al-
loknesis, a condition in which normally innocuous mechanical
stimuli cause itch (Akiyama et al., 2012; Gao et al., 2018;Wahlg-
ren et al., 1991). Moreover, there is evidence that the parabra-
chial nucleus (Campos et al., 2018; Mu et al., 2017) to which
NK1R+ neurons project (Akiyama et al., 2015) encodes both
mechanical and chemical itch. Our results show that the
NK1R+ neurons are dispensable for mechanical itch, which
suggests that the chemical and mechanical itch pathways do
not converge in the spinal cord on ascending NK1R+ projection
neurons.
NPY-Y1R Signaling Gates Mechanical Itch
Our analysis reveals a key role for NPY in regulating mechanical
itch and touch sensitivity. We propose that NPY-Y1 signaling
functions in healthy animals as a homeostatic mechanism to
adjust the output of the LTMR circuitry, thus ensuring the correct
discrimination between itch and other innocuous light touch
sensations. Recently, it has been reported that NPY suppresses
itch (Gao et al., 2018), although the site of action and the cellular
basis for this activity were not described. Our studies show
endogenous NPY acts on Y1+ neurons in the dorsal horn to regu-
late mechanical itch, the same cells that are required for the
chronic itch phenotype in NPY::Cre IN ablated mice (Figure 3).
We cannot completely exclude the possibility that NPY-Y1
signaling in sensory afferents also contributes to the modulation
of mechanosensory transmission; however, this is unlikely, as in
these neurons Y1 is co-expressed with CGRP (Brumovsky et al.,
2002), a marker of high-threshold mechanoreceptors (Lawson
et al., 2002).
While our results show the inhibitory effects of NPY::Cre IN
activation are largely abolished by Y1 blockade, the present
study does not eliminate a role for GABA or glycine in the regu-
lation of the mechanical itch pathway. Rather, Y1-mediated
inhibition may operate in conjunction with fast inhibitory path-
ways (Akiyama et al., 2011; Ralvenius et al., 2018) to regulate
the sensitivity of the dorsal horn mechanosensory circuitry
over longer time scales than those controlled by ionotropic
feedforward inhibition. It is also possible that peptidergic
signaling between NPY::Cre and Y1+ neurons contributes to
the inhibition of mechanical itch by counterstimuli, a role that
would be consistent with our observation that after-dischargeCell Reports 28, 625–639, July 16, 2019 635
spiking is enhanced following brushing of the hairy skin in NPY::-
Cre IN-ablated mice (Bourane et al., 2015a).
The central inhibition of mechanical itch by NPY::Cre INs par-
allels the inhibitory regulation of chemical itch by the B5-I INs
(Figure 7L) (Chiang et al., 2016; Kardon et al., 2014; Ross
et al., 2010). B5-I INs are a subset of lamina I-II inhibitory INs
that express the transcription factor Bhlhb5. These cells sup-
press activity in a tonic manner (Huang et al., 2018; Kardon
et al., 2014; Ross et al., 2010) and in response to counterstimuli
(Hachisuka et al., 2016; Kardon et al., 2014). The B5-I INs
include the spinal INs that express the neuropeptide dynorphin,
the endogenous agonist of kappa opioid receptors, and as in
mechanical itch, a neuropeptidergic mechanism is proposed
to regulate the chemical itch pathway in a tonic manner (Huang
et al., 2018; Kardon et al., 2014; however, also see Duan et al.,
2014).
Several studies have found that NPY exerts analgesic effects
via two of the five identified mammalian NPY receptors, the Y1
and Y2 receptors, in neuropathic, inflammatory, and some
forms of acute pain (Diaz-delCastillo et al., 2018; Duggan
et al., 1991; Hua et al., 1991; Intondi et al., 2008; Naveilhan
et al., 2001; Solway et al., 2011; Taiwo and Taylor 2002). Y1
signaling is also required for normal sensitivity to heat (Naveil-
han et al., 2001). However, it was previously unclear whether
these effects are mediated by central or peripheral mechanisms
(Diaz-delCastillo et al., 2018; Gibbs et al., 2004; Moran et al.,
2004). We find that ablation of Y1Cre neurons or deletion of the
Y1 gene within the dorsal horn has no effect on acute, thermal,
or chemical nociception (Figure 4), strongly indicating that they
are instead mediated by peptidergic Y1+ nociceptive afferents
(Brumovsky et al., 2002), rather than Y1+ neurons in the dorsal
horn. This finding further suggests that the mild Y1-dependent
inhibition of acute pain and dynamic touch observed following
activation of the NPY::Cre INs (Figure 7) entails ectopic inhibi-
tion of Y1+ primary afferents, and that other inhibitory neurons
play a more prominent role in gating these modalities under
physiological conditions.
In summary, this study demonstrates that Y1+ neurons form
an excitatory pathway within the dorsal horn for the transmis-
sion of mechanical itch, and that the flow of information through
this pathway is regulated by inhibitory NPY-Y1 signaling to
maintain normal touch discrimination. We propose that dysre-
gulation of this pathway following failure of the gating mecha-
nism may drive the development of neuropathic chronic itch.
It has been suggested that increases in mechanical itch sensi-
tivity in mice following the loss of Merkel cells due to aging or
dry skin might be due to reduced cutaneous input to inhibitory
NPY-expressing INs, although this has not been tested (Feng
et al., 2018). There is also evidence that the disruption of NPY
signaling in humans may contribute to chronic itch (Reich
et al., 2013). Notably, psoriasis patients presenting with pruritus
have reduced NPY serum levels, which are negatively corre-
lated with the intensity of itch (Reich et al., 2007). In view of
the central contribution NPY signaling makes to the inhibitory
regulation of itch sensation, Y1 signaling merits investigation
as a therapeutic target for the treatment of chronic itch, a con-
dition that rivals chronic pain in the severity of its impact on qual-
ity of life (Kini et al., 2011).636 Cell Reports 28, 625–639, July 16, 2019STAR+METHODS
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Martyn
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
All protocols for animal experiments were approved by the IACUC of the Salk Institute for Biological Studies according to NIH guide-
lines for animal experimentation. Male and female mice were used in all studies. Animals were randomized to experimental groups
and no sex differences were noted.
The Y1Cre knockin mouse line was generated by Padilla et al. (Padilla et al., 2016). An FRT-flanked neomycin cassette was removed
by crossingwith the FLPo-10deleter strain (Wu et al., 2009), as describedbyPadilla et al. (Padilla et al., 2016). TheY1::eGFP transgenic
reporter mouse line (RRID:MMRRC_010554-UCD) was generated by the Gene Expression Nervous System Atlas (GENSAT)
project. The following mouse lines were also used in this study: NPY::Cre (Bourane et al., 2015a), SstCre (Taniguchi et al., 2011),
SstFlpO (He et al., 2016), Lbx1Cre (Sieber et al., 2007), Lbx1FlpO (Bourane et al., 2015a), Ai14lsl-Tom (Madisen et al., 2010), Ai65ds-Tom
(Madisen et al., 2015), R26ds-hM3D (Sciolino et al., 2016), R26ds-hM4D (Bourane et al., 2015a), R26ds-ReaChR (Hooks et al., 2015),
Tauds-DTR (Britz et al., 2015), NPY KO (Karl et al., 2008), Y1f/f (Bertocchi et al., 2011), GRP::eGFP (Mishra and Hoon, 2013),
R26ds-HTB (Bourane et al., 2015b), R26lsl-TVA (Seidler et al., 2008).
METHOD DETAILS
Immunohistochemistry
Micewere euthanized by a single intraperitoneal (i.p.) injection (10 ml g-1 bodyweight) of ketamine (10mgml-1) and xylazine (1mgml-1)
immediately prior to perfusion with 20 mL ice-cold 4% paraformaldehyde in PBS. Spinal cords and DRG (lumbar levels L4 and L5)
were dissected and post-fixed for 1 h at RT, then washed 3 times in PBS and cryoprotected in 30% sucrose-PBS (w/v) overnight
at 4C. Tissue was embedded in Tissue-Tek OCT Compound (Sakura Finetek) and cryosectioned at 40 mm. Sections were dried
at RT and stored at 20C. Sections were washed once with PBS (5 min), blocked with a solution of 10% donkey serum in PBT
(PBS, 0.1% Triton X-100) for 1 h at RT and then incubated overnight at 4Cwith primary antibodies in a solution of 1% donkey serum
in PBT. Sections were then washed 3 times (15 min each) in PBT before being incubated for 2 h at RT with fluorophore–conjugated
secondary antibodies (1:1000; Jackson Laboratories) in a solution of 1% donkey serum in PBT. Sections were again washed 3 times
(15 min each) in PBT before being mounted with Aqua-Poly/Mount (Polysciences). A Zeiss LSM 700 confocal microscope was used
to capture images. 3-5 spinal cords were analyzed for each condition. ImageJ software was used to assess immunofluorescence,
with thresholds set according to signal intensity (Jensen, 2013).
The following primary antibodies were used in this study: rabbit a-Calbindin (1:1,000; Swant), rabbit a-Calretinin (1:1,000; Swant),
sheep a-CGRP (1:1,000; Abcam), rabbit a-cMaf (1:5000; C Birchmeier, MDC, Berlin), goat a-cRet (1:250; R&D Systems), goat a-CTB
(1:4000; List Laboratories), rabbit a-DsRed (1:1000; Clontech), mouse a-Gephyrin (1:8000; Synaptic systems); rabbit a-GFAP (1:500;
Dako), chicken a-GFP (1:000; Aves), goat a-GFP (1:1000; Abcam), rabbit a-GRPR (1:1000; Abcam), rabbit a-GRPR (1:100; MBL),
guinea pig a-Lmx1b (1:1000; M Goulding), mouse a-NeuN (1:1000; Millipore), rabbit a-NK1R (1:500; Advanced Targeting Systems),
rabbit a-NPY (1:1000; Peninsula Lab), rabbit a-Parvalbumin (1:1000; Swant), rabbit a-Pax2 (1:200; Zymed), rat a-RFP (1:1000;
Chromotek), rabbit a-PKCg (1:1000; Santa Cruz), goat a-RORa (1:100; Santa Cruz), rabbit a-S100b (1:500; Dako), goat TrkB
(1:1000; R&D Systems), goat a-TrkC (1:1000; R&D Systems), guinea pig a-VGAT (1:1000; Synaptic Systems), guinea pig a-vGluT1
(1:1000; Millipore). In addition, Alexa Fluor 647-conjugated isolectin GS-IB4 fromGriffonia simplicifolia (Invitrogen) was used at 1:500.
In Situ Hybridization
For in situ hybridization (ISH), mice were perfused with 4% paraformaldehyde in a solution of 0.1% diethyl pyrocarbonate in PBS
(PBS-DEPC), post fixed for 1 h at RT, washed 3 times with PBS-DEPC and cryopreserved overnight in 30% sucrose in PBS-
DEPC. Spinal cords were embedded in Tissue-Tek and stored at 80C. Spinal cords were then cryosectioned at 16 mm, and
sections were hybridized with an antisense RNA probe overnight at 64C. Sections were washed twice in a solution of 1 x saline-
sodium citrate buffer, 50% formamide, and 0.1% Tween-20 at 64C for 30 min and blocked with a solution of 0.1% Tween 20 in
maleic acid buffer (MABT) containing 2% blocking reagent and 10% inactivated sheep serum for 2 h at RT. Sections were then
incubated overnight with sheep a-digoxigenin-alkaline-phosphatase Fab fragments (1:2000; Roche), washed twice in MABT and
revealed with a staining solution of NBT (1:500, Roche) and BCIP (1:600, Roche). An Olympus VS-120 Virtual Slde Scanning
Microscope was used for imaging. For double staining analyses, tdTomato fluorescence was imaged before ISH was performed.
ISH images were later pseudo-colored and superposed onto the tdTomato signal in Photoshop (Adobe Systems). For quantification,
three sections from each of three spinal cords were analyzed per condition, and only cells with clearly visible nuclei were scored.
Rabies Virus Tracing and Morphological Analyses
For the sparse labeling of Y1Cre neurons required for morphological reconstruction, EnvA-pseudotyped, DG-dsRed-Express rabies
virus (100 ml, 1.283 108 units ml-1) was injected unilaterally into the lumbar spinal cord of P10 Y1Cre; R26lsl-TVA mice (Bourane et al.,
2015b). For the transsynaptic tracing studies, bilateral injections of EnvA-pseudotyped, DG-mCherry (250 ml, 3.3 3 1010 units ml-1)
were made into the lumbar cord of Y1Cre; Lbx1FlpO; R26ds-HTB animals at P5.
Briefly, mice were anesthetized by administering 2.5% isoflurane via a nose cone. The skin over the lumbar region of the dorsal
spinal cord was incised and a laminectomy was performed at the T13-L1 level. After removal of the dura mater with a fine needlee3 Cell Reports 28, 625–639.e1–e6, July 16, 2019
to expose the spinal cord, virus was injected via a fine glass capillary inserted into the dorsal spinal cord. The needle was left in the
cord for 1 min after injection to prevent outflow. The skin was closed using Vetbond (3M) and Reflex Skin Closure System (CellPoint
Scientific). Mice were perfused 5 days post-injection and processed for immunohistochemistry.
AAV Virus Tracing of Synaptic Connections
To visualize synaptophysin at presynaptic boutons, injections of AAV2/1-hSyn-DIO-SypHTomato (0.5 ml, 1.63 1012 units ml-1) were
made into the lumbar spinal cord of P37 Y1::eGFP mice as described above. Spinal cords were then processed for immunohisto-
chemistry at P60.
Retrograde Cholera Toxin-b Labeling of Cutaneous Sensory Neurons
Postnatal day (P) 39 Y1Cre; Ai14lsl-Tom mice were anesthetized with 2.5% isoflurane in O2, and Alexa Fluor 647-conjugated cholera
toxin subunit B (CTb) (0.5 ml, 2.5 mg ml-1 in 0.9% sterile saline; Molecular Probes) was injected into either the hairy skin of the hindlimb
or the glabrous skin of the plantar hindpaw with a fine glass capillary. Mice were perfused at 3 days post injection and processed for
immunohistochemistry.
Cell Ablation
For ablation of neurons expressing Cre and FlpO drivers in addition to Tauds-DTR, mice were injected with diphtheria toxin (DT; 50 ng
kg-1 in 0.9% sterile saline, i.p.; List Biological Laboratories) at P28 and P31 (Bourane et al., 2015a). Analysis of spontaneous
scratching in mice expressing NPY::Cre (and relevant controls) was performed at P35, 7 days following the first DT injection. For
the double-Cre ablation experiment, controls were positive for Cre and Tauds-DTR alleles but lacked the Lbx1FlpO allele and did
not therefore express the diphtheria toxin receptor; however, all mice received DT. All other behavioral testing was performed
14-21 days following the first injection; controls were littermates of experimental animals and had identical genotypes but received
injections of 0.9% sterile saline instead of DT.
To ablate cells cell populations with saporin-conjugated receptor ligands, P28 mice were given a single intrathecal (i.t.) injection of
either bombesin-saporin (400 ng in 5 mL 0.9% sterile saline; Advanced Targeting Systems) (Bourane et al., 2015a) to ablate GRPR+
cells or [Sar9, Met(O2)
11]-substance P-saporin neurons (100 ng in 5 mL 0.9% sterile saline; Advanced Targeting Systems) to ablate
NK1R+ neurons (Wiley and Lappi, 1999). Littermate controls received blank saporin (equal mass in 5 mL 0.9% sterile saline; Advanced
Targeting Systems). Behavioral testing and assessment of ablation efficiency by immunohistochemistry were performed 14 days
later at P42.
For i.t. injections, mice were anesthetized with 2.5% isoflurane in O2, delivered via a nose cone. The caudal paralumbar region was
then secured between the thumb and index finger, and a 30-gauge needle was inserted into the fifth intervertebral space until it
elicited a tail flick. To prevent outflow, the needle was held in place for 10 s and turned 90 prior to withdrawal.
Drug Administration
Synthesis of the selective Y1 receptor agonist [Leu31, Pro34]-Neuropeptide Y ([Leu31, Pro34]-NPY; YPSKPDNPGEDAPAEDMARYYS
ALRHYINLLTRPRY-NH2) (Fuhlendorff et al., 1990) was performed on a Gyros Protein Technologies, Inc. Tribute peptide synthesizer
equipped with real-time UV monitoring, using standard Fmoc chemistry, in the Salk’s Peptide Synthesis Core. The resultant crude
peptide was purified by the Salk’s Proteomics Core to > 98% using HPLC. The final, purified product gave a single peak of predicted
mass (4240.7 Da) by MS analysis. The peptide was administered in solution at pH 7.
Neuropeptide Y (NPY; Tocris) and [Leu31, Pro34]-NPY were dissolved in 0.9% sterile saline. Clozapine N-oxide (CNO; Sigma) and
the Y1 receptor antagonist BIBP 3226 (Tocris) (Jacques et al., 1995) were dissolved in DMSO, which was then diluted with 0.9% ster-
ile saline such that the concentration of DMSO did not exceed 1% in injected solutions. The Y1 receptor antagonist BMS 193885
(Tocris) (Poindexter et al., 2002) was dissolved in sterile water, which was then rendered isotonic with glucose (5% w/v).
CNO was administered by i.p. injection at 2 mg kg-1. Other drugs were administered as indicated.
CNO, NPY, [Leu31, Pro34]-NPY, and BIBP 3226 were injected 15 min prior to behavioral testing. BMS 193885 was observed to
cause inactivity for 30 min following i.p. injection, as previously reported (Antal-Zimanyi et al., 2008); behavioral testing in BMS
193885-injected mice and vehicle-injected controls was therefore conducted from 30 to 60 min post injection. WT mice injected
with NPY, [Leu31, Pro34]-NPY, BIBP 3226 or BMS 193885 were compared to vehicle-injected littermate controls.
To take into account differences in phenotype severity between NPY::Cre; Lbx1FlpO; Tauds-DTR mice treated with DT and between
Lbx1Cre; Y1f/f mice, paired t tests were conducted to assess the effects of Y1 drugs. Recordings were made at 4 h intervals on the
same day.
For chemogenetic silencing and activation experiments, all mice received CNO. Control mice were positive for the Cre and
R26ds-hM4D or R26ds-hM3D alleles but lacked the Lbx1FlpO allele and did not therefore express the hM4D or hM3D receptor.
Electrophysiology
For slice preparations, P14-28micewere anaesthetized by i.p. injection of urethane (10 ml/g) and transcardially perfusedwith oxygen-
ated ice-cold dissecting/recovery artificial cerebrospinal fluid (ACSF; NaCl, 95 mM; KCl, 2.5 mM; NaHCO3, 26 mM; NaH2PO4H2O,
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cords were then isolated in ice-cold dissecting/recovery ACSF before being embedded in low-melting agarose at 33C. A vibratome
(Leica VT1000S) was used to cut 300 mm transverse slices from lumbar segments L1-5 in ice cold dissecting/recovery ACSF. Slices
were then allowed to recover in dissecting/recovery ACSF at34C for 1 h before being secured in a recording chamber continuously
perfused with recording aCSF (NaCl, 125 mM; KCl, 2.5 mM; NaHCO3, 26 mM; NaH2PO4H2O, 1.25 mM; MgCl2, 1 mM; CaCl2, 2 mM;
glucose, 20 mM; ethyl pyruvate, 5 mM) at RT. At all stages, ACSF was equilibrated with carbogen (95% O2; 5% CO2). Experiments
were performed at RT.
Patch-clamp electrodes (3–5 MU) were pulled on a horizontal puller (Sutter Instrument, Novato, CA) from borosilicate glass (World
Precision Instruments, Sarasota, FL). Signals were amplified and filtered (4 kHz low-pass Bessel filter) with a MultiClamp 700B
amplifier (Molecular Devices) and acquired at 50 kHz with a Digidata 1440A A/D board and pCLAMP software (Molecular Devices).
Neuronal firing was elicited by injecting depolarizing currents ranging from 0 to 200 pA in 20 pA increments for 1 s at intervals of 10 s.
For ReaChR-mediated stimulation of NPY::Cre INs, a single LED optic fiber source (2 mW output at 591 nm) was positioned
10 mm from the surface of the slice, illuminating its entire surface. Stimulation was delivered at a pulse width of 5-20 ms. All drugs
were bath applied. Kynurenic acid (1.5 mM; Sigma) and strychnine (1 mM; Sigma) were dissolved in water. Picrotoxin (60 mM; Sigma)
was dissolved in DMSO such that the concentration of DMSO in recording solution did not exceed 0.1% (v/v). A liquid junction
potential of 14 mV was corrected offline.
Behavioral Testing
Littermate controls were used for behavioral tests, and the experimenter was blinded to genotype/treatment. Animals were habitu-
ated to the behavioral testing apparatus for 1 h on each of the two days preceding data collection. Tests were conducted at P42-P49,
or at P35 (7 days following the first injection of DT) in experiments to assess spontaneous scratching induced by ablation ofNPY::Cre
neurons.
Spontaneous Itch
To quantify scratching induced in the absence of an experimental mechanical stimulus (spontaneous itch), mice were placed
in a plastic chamber and video recorded for a period of 30 min; bouts of hindlimb scratching were counted offline (Bourane et al.,
2015a).
Nape Stimulation Assay
To quantify itch-related scratching behaviors induced by mechanical stimulation of the hairy skin, mice were placed in a plastic
chamber and a 0.16 g von Frey hair was applied to the nape for 3 s (as per Bourane et al., 2015a). Hindlimb scratching responses
over 10 trials were counted and reported as a percentage.
von Frey Assay
To assess the sensitivity of the glabrous skin to light punctate mechanical stimulation, mice were placed in a plastic chamber on an
elevated wire grid and the lateral plantar surface of the hindpaw was stimulated with calibrated von Frey monofilaments (0.008-4 g).
The paw withdrawal threshold for the von Frey assay was determined by Dixon’s up-down method (Chaplan et al., 1994).
Dynamic Touch Test
To assess the sensitivity of the glabrous skin to light dynamic touch, mice were placed in a plastic chamber on an elevated wire grid
and the plantar surface of the hindpawwas stimulated by light stroking with a fine paintbrush in a heel-to-toe direction (Bourane et al.,
2015b). The test was repeated 10 times at 10 s intervals between trails, and the percentage of positive paw withdrawal trials was
calculated.
Pinprick Test
To assess the sensitivity of the glabrous skin to acute painful stimuli, mice were placed in a plastic chamber on an elevated wire grid
and the plantar surface of the hindpaw was stimulated with an Austerlitz insect pin (Tip diameter: 0.02 mm; Fine Science Tools). The
pin was gently applied to the plantar surface of the hindpaw without moving the paw or penetrating the skin. The pin stimulation was
repeated 10 times on different paw areas with a 1-2 min interval between trails, and the percentage of trials in which mice responded
with paw withdrawal was calculated.
Randall-Selitto Test
Prior to testing, mice were placed in a plastic restraining tube and allowed 5 min to acclimatize. A Randall-Selitto device (IITC, USA)
was used to apply slowly increasing pressure to a point midway along the tail until the animal showed clear signs of discomfort. This
pressure was recorded as the pain threshold. Three trials taken at 2 min intervals were performed to calculate the average threshold
for each animal.
Chemical Nociception Tests
To assess pain induced by chemical agents, a 30-gauge needle was used to inject 6 mL of either capsaicin (1 mg in 10 mL 9% saline
containing 7% Tween-80) or formalin (2% in 9% saline) subcutaneously into the plantar hindpaw. The time spent licking, flinching,
and biting the injected hindpaw was recorded for 15 min (capsaicin) or 1 h (formalin) post-injection. Phase I was defined as the first
10 min post injection and phase II was defined as the period 10-60 min post injection.
Hot Plate Test
Mice were placed on a hot plate (IITC, USA) set at 46C, 50C or 54C and the latencies to hindpaw flinching and licking were
measured. All animals were tested sequentially with a minimum of 5 min between each test. To prevent tissue damage, a cutoff
time was set at 60 s for assays at 46C and 50C, and 30 s for 54C.e5 Cell Reports 28, 625–639.e1–e6, July 16, 2019
Hargreaves Test
To measure radiant heat pain, mice were placed in a plastic chamber and the plantar hindpaw surface was exposed to a beam of
radiant heat (IITC, USA). The latency to paw withdrawal was determined in one trial per hindpaw and averaged per animal, with a
10 min interval between trials. A cutoff time of 30 s was set to prevent tissue damage.
Chemical Itch Test
The pruritogens chloroquine (200 mg; Sigma), histamine (100 mg; Sigma), compound 48/80 (100 mg; Sigma) and SLIGRL-NH2
(SLIGRL; 100 nM; Abcam) were dissolved in 0.9% sterile saline and injected intradermally behind the ear in a volume of 50 ml. The
behavior of each animal was video-recorded over the following 30 min, and the number of hindpaw scratch bouts was counted.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were analyzed in GraphPad Prism 6 for Windows, Version 6.01 (Graphpad Software) or Excel 2016 (Microsoft) by two-tailed,
unpaired t tests, unless otherwise indicated. See figure legends for details of statistical analyses. p < 0.05 was considered to be
statistically significant. All data are presented as the mean ± standard error of the mean (SEM).
All tdTomato signals were enhanced by RFP antibody staining prior to analysis.Cell Reports 28, 625–639.e1–e6, July 16, 2019 e6
